|
Market Closed -
Other stock markets
|
After hours 07:59:55 pm | |||
| 193.01 USD | -2.77% |
|
192.66 | -0.18% |
| Jul. 14 | Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating | MT |
| Jul. 13 | Citigroup Downgrades ResMed to Neutral From Buy, Adjusts Price Target to $235 From $270 | MT |
Group ResMed, Inc.: Relations chart
Private companies belonging to the same group as RESMED, INC.
| Company | Manager |
|---|---|
ResMed Pty Ltd.
 ResMed Pty Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Mick Farrell |
ResMed Corp.
 ResMed Corp. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Mick Farrell |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
